HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Makio Takeda Selected Research

Procollagen Type I

11/2010Didecyldimethylammonium chloride induces pulmonary inflammation and fibrosis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Makio Takeda Research Topics

Disease

6Ganglion Cysts (Ganglion)
09/2017 - 08/2002
5Starvation
05/2014 - 02/2008
4Inflammation (Inflammations)
03/2015 - 01/2010
4Lung Injury
11/2013 - 01/2010
3Hypertrophy
01/2018 - 01/2013
3Neoplasms (Cancer)
01/2016 - 01/2003
2Anemia
01/2018 - 01/2013
2Paralysis (Palsy)
06/2012 - 01/2004
1Hyperplasia
01/2018
1Malaria
01/2016
1Necrosis
03/2015
1Pulmonary Fibrosis (Fibrosing Alveolitis)
11/2013
1Fibrosis (Cirrhosis)
11/2010
1Lung Diseases (Lung Disease)
11/2010
1Pneumonia (Pneumonitis)
11/2010
1Respiratory Tract Diseases (Respiratory Tract Disease)
01/2010
1Virus Diseases (Viral Diseases)
01/2004
1Body Weight (Weight, Body)
12/2003
1Liver Cell Adenoma (Hepatocellular Adenoma)
01/2003
1Hepatocellular Carcinoma (Hepatoma)
01/2003
1Atrophy
10/2002

Drug/Important Bio-Agent (IBA)

5DDTIBA
01/2016 - 01/2003
3didecyldimethylammonium (didecyldimethylammonium chloride)IBA
11/2013 - 11/2010
3Interleukin-6 (Interleukin 6)IBA
01/2013 - 01/2010
2LipidsIBA
01/2018 - 07/2013
2crustacean cardioactive peptideIBA
12/2015 - 02/2008
2neuropeptide FIBA
12/2015 - 03/2012
2LipopolysaccharidesIBA
03/2015 - 01/2013
2N,N- dimethyl- N- hexadecyl- 1- octadecylammonium (DDAC)IBA
11/2013 - 11/2010
2AntioxidantsIBA
11/2013 - 01/2010
2AmylasesFDA Link
01/2013 - 03/2012
2Peptide Hydrolases (Proteases)FDA Link
01/2013 - 03/2012
2CaspasesIBA
12/2012 - 01/2010
2Proteins (Proteins, Gene)FDA Link
12/2012 - 02/2008
2AntibodiesIBA
02/2008 - 12/2004
2AntigensIBA
05/2007 - 12/2004
1LipofuscinIBA
01/2018
18-Hydroxy-2'-DeoxyguanosineIBA
01/2018
1Glucose (Dextrose)FDA LinkGeneric
01/2018
1allatotropinIBA
09/2017
1Pharmaceutical PreparationsIBA
03/2015
1Amino AcidsFDA Link
05/2014
1UbiquitinsIBA
05/2014
1Complement System Proteins (Complement)IBA
05/2014
1Transforming Growth Factors (Transforming Growth Factor)IBA
11/2013
1GlycogenIBA
07/2013
1Uric Acid (Urate)IBA
07/2013
1IronIBA
01/2013
1SilkFDA Link
12/2012
1bifenazateIBA
06/2012
1diazeneIBA
06/2012
1Lipase (Acid Lipase)FDA Link
03/2012
1Procollagen Type IIBA
11/2010
1Local Anti-Infective Agents (Antiseptics)IBA
11/2010
1Messenger RNA (mRNA)IBA
11/2010
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
11/2010
1Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
11/2010
1CC ChemokinesIBA
11/2010
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2010
1ArsenicIBA
01/2010
1chromium hexavalent ionIBA
01/2010
1ChromiumIBA
01/2010
1Thioredoxin-Disulfide ReductaseIBA
01/2010
1Glutathione (Reduced Glutathione)IBA
01/2010
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2010
1Mitogen-Activated Protein KinasesIBA
01/2010
1arsenic acid (arsenate)IBA
01/2010
1diapause hormoneIBA
02/2008
1Bromodeoxyuridine (BrdU)IBA
02/2008
1Arylalkylamine N-AcetyltransferaseIBA
02/2008
1CryptochromesIBA
02/2008
1NeuropeptidesIBA
02/2008
1Histones (Histone)IBA
02/2008
1Monoclonal AntibodiesIBA
01/2004
1Methoxychlor (Metox)IBA
10/2002
1Biogenic MonoaminesIBA
08/2002

Therapy/Procedure

1Aftercare (After-Treatment)
11/2010